We identified the following genes as having decreased expression in tumour lines compared to controls: FGF2, APAF1, CFLAR, XIAP, STMN1, WEE1, ERCC5, LIG4, PPP1R15A, OCLN, SOX10, ARNT, LDHA, ATP5A1, COX5A, CPT2, PFKL, UQCRFS1, ETS2, IGFBP3, IGFBP5, IGFBP7, SOD1, TBX2, PINX1, TINF2, TNKS, and TNKS2 (out of range). This evidence concerns the gene STMN1 and neoplasm.